Introduction
It has been suggested that gene transfer into the liver using retroviruses would allow the development of clinical protocols to treat the clinical manifestations of some inherited metabolic diseases. [1] [2] [3] [4] [5] Retroviruses are attractive vectors for gene transfer in the liver, [6] [7] [8] [9] because they integrate into the chromosomal DNA of the target cell. 10, 11 Since hepatocytes are long-lived cells, 12 the expression of the transgene is stable. [13] [14] [15] The integrated gene will persist for the life time of the transduced cell and will be present in cells that arise by subsequent cell division.
Delivering retroviruses targeted to hepatocytes in vivo requires their injection directly into the hepatic artery, the biliary tract but more often into the portal blood flow. [16] [17] [18] In the normal liver, adult hepatocytes are normally quiescent, highly differentiated cells. 19 They are not susceptible to retrovirus transduction that requires active DNA replication for integration into the host cell genome. 20 To overcome this condition, retroviruses are most viruses as perfusate. High hepatocyte transduction rates (up to 34 .4%) were obtained. PCR analysis showed no provirus in extrahepatic organs. Viral titrations performed simultaneously (inflow and outflow liver lines) showed that after 1 h of perfusion (up to 30 successive liver passages) retroviruses were still detected in the liver outflow perfusate (up to 2.0 × 10 7 ffu/ml). Washing the liver for 30 min dramatically decreased the leakage of retroviruses in the outflow. In order to be of clinical use, the injection of retroviruses targeted to hepatocytes in vivo should be done while the liver is completely excluded from the splanchnic circulation to avoid any extrahepatic retrovirus diffusion. Gene Therapy (2000) 7, 1816-1823.
often delivered into the portal vein following partial hepatectomy. Partial resection of the liver is followed by a regenerative phase. 21 Hepatocytes enter the cell cycle during this process. By taking advantage of nuclear envelope breakdown during mitosis, retroviruses can enter the nucleus and integrate the host cell genome. 22 However, until now hepatocyte gene transfer efficiency obtained with this method rarely exceeds 1%.
To date, little is known about the retroviral hepatocyte uptake mechanism after their injection into the portal vein. Not all the retroviruses vectors injected into the portal vein could be taken up by liver cells in a single passage through the liver. If this is true, some of the retroviruses injected into the portal vein can reach the systemic circulation, and transduce hepatocytes, but only after successive liver passages. On the other hand, once in systemic circulation, they could also transduce other organs, including germinals cells. In order to be of clinical use, systemic diffusion of retroviruses must be avoided.
One possible way to limit extrahepatic diffusion of retroviruses could be the utilization of an ex vivo step, in the isolated, perfused liver. Gene transfer could be done by perfusing retroviruses under ex vivo isolated perfusion conditions during the S phase of the hepatocyte cell cycle, followed by orthotopic liver transplantation of the transduced liver. In a previous study, we have demonstrated that rat liver regeneration during hepatocyte cell cycle S phase in isolated ex vivo normothermal conditions develops in a manner similar -regarding the quantity and timing of DNA synthesis -to liver regeneration found in vivo after partial hepatectomy. After 2 and 6 h of isolated perfusion of regenerating and normal livers respectively, successful orthotopic liver transplantation could be obtained. 23 The perfusion of an intact liver, completely excluded from the circulation, with minimal exposition of extrahepatic organs, could simplify this strategy. The aim of this work was to establish a clinically relevant system for retrovirus-mediated gene transfer in an in vivo, in situ normothermal isolated, perfused regenerating rat liver and to study the transgene expression in the hepatocytes.
Results
Partial hepatectomy All rats survived partial hepatectomy which was performed with minimal trauma to the remaining liver lobes and surrounding structures.
In vivo, in situ normothermal isolated perfused regenerating rat liver The duration of the in vivo, in situ normothermal isolated, perfused regenerating rat liver with recirculating culture supernatant was 60 min, followed by a 30-min infusion period with culture medium without retrovirus in a single liver passage. The perfusion was carried out from 25.6 ± 1.0 to 27.1 ± 1.0 h after partial hepatectomy. All livers presented homogeneous aspect during perfusion. The mean perfusion flow rate was 12.7 ± 1.2 ml/min. The mean oxygen consumption was 1.6 ± 0.2 mol/min/g of liver. The number of liver passages of the culture supernatant was 30.3 ± 3.4 (group I, volume = 25 ml) and 15.3 ± 1.2 (group II, volume = 50 ml). The mean volume of culture medium without retroviruses used to wash out the liver was 381.6 ± 35.9 ml. During perfusion, bile changed to a red color (probably indicating that red phenol present in the medium was eliminated in the bile) and returned to normal yellow color as soon as the normal liver vascularization was restored. The duration of warm ischemia of the liver at the beginning/end of the isolated, perfused rat liver was less than 30 s. Twelve rats survived the in vivo, in situ normothermal isolated regenerating liver perfusion. Table 1 shows the simultaneous retroviral titration performed in the inflow and outflow lines during the rat liver perfusion. Considering a liver passage of the perfusate at 30 and 60 min, the difference (%) between the retrovirus titer entering (inflow line) and leaving (outflow line) the liver means that retroviruses are uptaken (from 5 to 50%) or released (from 5 to 41%) by the liver, during a liver passage. All retroviral titrations were negative in samples taken from the bile during the in vivo, in situ isolated perfusion (at 30, 60 and 90 min) and from a sample taken after liver revascularization. Table 2 shows the retroviral titration performed in the outflow line during rat liver perfusion. After 30 min of liver washing, the titer of retroviruses that were not bound to liver cells could be decreased to 18 ffu/ml.
Hepatic retroviral uptake mechanism
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Histology Subcapsular necrosis was observed. The extent of necrosis was variable, but mostly limited to minimal pale coagulative necrotic foci. They were attributable to the clamp placed in the suprahepatic vena cava that compressed the parenchyma of caudate lobe. Centrilobular cholestasis, bile lakes and cholangitis were absent. Edematous widening of the portal tracts, slight ductular proliferation and duct dilatation were uncommon.
Distribution and quantification of ␤-galactosidase positive hepatocyte The percentage of ␤-galactosidase-positive hepatocytes/ total number of hepatocytes is shown in Table 3 . High tranduction rates (up to 32.4 ± 19.3% and 34.4 ± 19.1%) were obtained with 25 (group I) or 50 ml (group II) of culture supernatant, respectively, with high virus titer (up to 1.5 ± 0.6 × 10 8 ffu/ml). Figure 1 shows that the lobular distribution of hepatocytes expressing cytoplasmic ␤-galactosidase activity were maximal in the periportal and mediolobular zones of the acinus. No endogenous ␤-galactosidase activity was found in the liver of normal rats.
␤-galactosidase positive cells in other organs
A very low intensity of ␤-galactosidase positive activity was detected in the spleen, kidney and testis of rats where livers were perfused with 25 (group I) or 50 ml (group II) of culture supernatant. The same organs of normal rats also presented a very low intensity of endogenous ␤-galactosidase positive activity.
PCR analysis
PCR analysis showed that the provirus pTG 5391 was present in liver DNA of rats perfused with culture supernatant, but was absent in the DNA isolated from all others organs in these same rats ( Figure 2 ).
Discussion
This study describes first a new model of gene transfer to hepatocytes through an in vivo, in situ perfusion of regenerating rat livers which could be of clinical relevance. Second, this model allowed us to evaluate the uptake of retrovirus by the regenerating liver.
Methods to deliver retroviruses into the liver via the portal vein are limited by the volume injected. [16] [17] [18] In our laboratory, using an in vivo asanguineous model of nonoxygenated perfusion of the regenerating liver, we have demonstrated that rat 24 and dog livers 25 can be transduced after infusion of retroviruses into the portal vein. However, hepatocyte transduction rates were lower than 5% in rats and 1% in dogs. The main limiting factor of the model described by Ferry et al 24 was the duration of portal vein cross clamping, limited to 20 min. Our model can overcome this obstacle. By taking advantage of the normal anatomy of the portal vein branches, a catheter placed through the portal vein drained the portal system. At the same time, the portal vein was used to perfuse the liver. The circulation in the extracorporeal portocavo-jugular shunt resulted from the pressure gradient between portal system and the right atrium. Another advantage of our method is that the ischemia/reperfusion time is reduced to less than 30 s. However, establishing the extracorporeal circulation and The liver was perfused in a recirculating way with fresh culture supernatant for 60 min. Livers were perfused with 25 ml, group I (1.5 ± 0.6 × 10 8 ffu/ml) or 50 ml, group II (1.4 ± 0.6 × 10 8 ffu/ml) of fresh culture supernatant. Difference (%) between retrovirus titer entering (inflow line) and leaving (outflow line) the liver means that retroviruses are taken up (−) or released (+) by the liver during a liver passage. 
The liver was perfused in a single passage for 30 min with 381.6 ± 35.9 ml of culture medium without retroviruses. Retroviral titration in the outflow line was performed every 5 min.
inflow line to the liver required about 30-45 min. During this period, the liver portal inflow was interrupted. Liver vascularization settled by the hepatic artery of which blood flow was likely to increase due to the hepatic arterial buffer response observed in case of decrease in portal blood flow. 26 The hepatic artery was only clamped immediately before establishing the outflow line of the liver. At the end of the experiment, the liver was immediately perfused through the portal vein once its ligature was removed.
The results shown in Table 1 emphasize the safety of gene transfer using retroviral vectors. First, all retroviruses delivered in the portal vein are not taken up by the liver in a single passage through the liver, thus they can reach the systemic circulation. Second, after 1 h of in vivo, in situ normothermal isolated, perfused liver (up to 15 and 30 successive liver passages), retroviruses are still detected in the outflow perfusate of the liver (up to 2.6 ± 0.5 × 10 7 and 2.0 ± 0.3 × 10 7 ffu/ml, respectively). Third, during a liver passage of the perfusate, retroviruses are usually taken up by the liver but they can also be released in the circulation. At 30 min, retroviruses released in the perfusate were found in six rats, while it was only observed in two rats at 60 min. This could be explained by the degree of attachment of the virus to the cell surface. Retroviruses bound to the cell surface are internalized with a half time of approximately 3.0 h. 27 At 60 min, resistance to disruption could be greater than at 30 min. Fourth, Table 2 shows that washing the liver for 30 min decreased considerably the leakage of retroviruses in the outflow (from 10 6 -10 7 to 10 2 -10). Viral titer has been considered the main limiting factor to obtain a better transduction rate in the liver. Efforts to concentrate retroviruses using centrifugation 28 and tangential filtration 29, 30 showed that target cell transduction rate increases proportionally with the virus titer. Kitten et al 31 described a high-producer cell line (10 8 ffu/ml) transducing 46 ± 17% of rat hepatocytes with retrovirus bolus-injected through the portal vein, without any concentration step. Recently, we also supported this hypothesis: we have described an alternative way (the biliary route), in which the volume of culture supernatant perfused (up to 40 ml) was compatible with rat survival. Up to 58.7 ± 23.6% of hepatocytes were transduced by retro- In vivo in situ normothermal isolated, perfused regenerating rat liver was performed in a recirculating way for 1 h. Perfusate volume was 25 ml, group I (titer of 1.5 ± 0.6 × 10 8 ffu/ml) or 50 ml, group II (titer of 1.4 ± 0.6 × 10 8 ffu/ml) of fresh culture supernatant.
viruses delivered through the rat biliary tract. 32 In the present study, high transduction rates were also obtained either with 25 (group I) or 50 ml (group II) of culture supernatant perfusion (Table 3) . Viral titer of each viral preparation was equivalent (1.4 to 1.5 ± 0.6 × 10 8 ). Considering that liver weight (right lateral and caudate lobes) was 3 to 3.5 g (1% of rat weight in a preliminary study) and considering that the average number of hepatocytes per gram of liver is approximately 10 8 , 3 to 3.5 × 10 8 hepatocytes were perfused with 25 × 1.5 ± 0.6 × 10 8 ffu (group I) or 50 × 1.4 ± 0.6 × 10 8 ffu (group II). The MOI (multiplicity of infection) 33 achieved in this model was 10.7 to 12.5 or 20 to 23.3 retroviral particles per hepatocyte, respectively, which can be considered high MOIs. However, the percentage of transduced hepatocytes was similar with both ratios. The similarity of both transduction rates as well as the lobular distribution of hepatocytes expressing ␤-galactosidase activity (predominantly in the periportal and mediolobular zones of the acinus) were in accordance with the particular kinetics of hepatocyte replication following partial hepatectomy. 34, 35 The infection of hepatocytes by retroviruses is dependent on high viral titer, but not of replication activity. Retroviruses can infect replicating and quiescent hepatocytes. However, hepatocyte retrovirus-transduction is a saturable, cell cycle dependent phenomenon: in the rat, 35% of hepatocytes are in S phase 24 h following partial hepatectomy. 19 It is consistent with the 32.4% and 34.4% of transduced hepatocytes of this study (Table 3) . After washing the liver for 30 min, a very low number of circulating retroviruses remained to transduce hepatocytes later that entered cell cycle after 24 h. Furthermore, no retrovirus diffusion to other organs than the liver was found since PCR analyses showed that the provirus was absent in DNA samples from these organs.
The bile duct is open (arrow) above the paramedian ducts draining the right lateral and caudate lobes. (c) The catheter is introduced into the bile duct and secured. The branch of the portal vein to the right part of the median lobe was dissected in the hilum and into the liver parenchyma (1 cm), and sectioned between ligatures. The remaining protal vein was dissected in the hilum up to the branch assigned to the left part of the median
The in vivo, in situ isolated perfused regenerating liver described in this work seems to represent a clinically relevant model. This model allows a selective retrovirusmediated gene transfer restricted to liver cells. The efficacy of this model is demonstrated by the high hepatocyte transduction rates. The length of perfusion time could be increased until it covered all the period of internalization of retroviruses into liver cells. This model should be evaluated in larger mammals such as primates, in order to improve the security related to retrovirusmediated gene transfer, as well as the expression of a therapeutic transgene in the liver.
Materials and methods
Animals
Inbred male Lewis rats weighing 300 to 350 g were purchased from CERJ (Le Genest-St-Isle, France) and were maintained on AO4 laboratory rat chow diet (UAR, Epinay-sur-Orge, France) and tap water ad libitum in identical housing units on a 12 h light and dark cycle. All animals were treated in accordance with the guidelines of the French Ministère de l'Agriculture.
Chemicals
Dulbecco's modified Eagle's medium (DMEM), nonessential amino acids, gentamycin, penicillin-streptomycin, newborn bovine serum (NBBS) were purchased from Gibco BRL (Eragny, France), fetal calf serum (FCS) from BioWhittaker (Gagny, France), 5-bromo-4-chloro-3-indolyl-␤-D-galactopiranoside (X-gal) from Biovalley (Conches, France), 1 kb DNA ladder, deoxynucleotide triphosphates (dNTPs) and TaqBead Hot Start Polymerase from Promega (Charbonnières, France). All other chemicals were from Sigma Chimie (St Quentin Fallavier, France).
Cell line and retroviral vector
Retrovirus vector pTG 5391 (LTR-lacZ-SV40 pro Puro-LTR) carries the Escherichia coli ␤-galactosidase (LacZ) gene under control of the LTR promotor, and the puromycin N-acetyl transferase gene 36 under control of the internal SV40 early promotor. Amphotropic packaging cells were generated from the human embryonic kidney cell line 293. 37 The packaging cells stably express F-MuLV strain FB29 gag/pol genes 38 and an amphotropic envelope gene derived from pPAM3, kindly provided by AD Miller (Fred Hutchinson Cancer Research Center, Seattle, WA, USA). Packaging cells were transfected with the plasmid pTG5391 by calcium phosphate precipitation 39 to isolate the retrovirus producer clone E17-12-TG5391 (Transgène SA, Strasbourg, France).
Culture conditions E17-12-TG5391 cells were cultured in DMEM supplemented with 4.5 g/l of glucose, 1 g/ml puromycin, 1% nonessential amino acids, 200 g/ml gentamycin and 10% heat inactivated FCS. Amphotropic packaging cells were seeded into 185 cm 2 culture flasks (Gibco BRL) at a density of 5 × 10 4 cells/cm 2 . Cells were grown at 37°C in a humidified atmosphere containing 5% CO 2 . Culture medium was changed every 2 days. Culture supernatant (virus production of 24 h in 25 ml of culture medium) was harvested (day 5) and was filtered through a 0.45 m nitrocellulose filter (Sartorius, Goettingen, Germany). Culture supernatant was used in the presence of polybrene at 8 g/ml final concentration. 24 NIH 3T3 fibroblasts were cultured in DMEM supplemented with 200 g/ml gentamycin and 10% heat inactivated NBBS. Cell number and viability were determined by trypan blue exclusion in a hemocytometer. galactosidase activity with X-gal protocol: 24 1 mg/ml 5-bromo-4-chloro-3-indolyl-␤-d-galactopyranoside (X-gal), 4 mmol/l potassium ferricyanide, 4 mmol/l potassium ferrocyanide and 2 mmol/l MgCl 2 in PBS in a final volume of 1 ml per well. The virus titer (ffu/ml) was calculated by counting a statistically representative number (250 to 400) of blue cells in the well and multiplied by the dilution factors. All point titrations were performed three times and counted blindly. The titer of each viral preparation was 1.4-1.5 ± 0.6 × 10 8 ffu/ml. The absence of replication-competent retrovirus was checked by NIH 3T3 mobilization assay. 40 
Retroviral vector titration
Figure 4 In vivo, in situ normothermal isolated rat liver perfusion technique. An extracorporeal shunt drained the blood flow from the portal vein and infrahepatic caval vein to the right external jugular vein. A silastic catheter was introduced in the right branch of the ortal vein, 2-3 mm beyound the gastroduodenal vein. The portal vein above the gastroduodenal vein was ligated around this catheter. Another catheter was introduced in the right lumbar vein. Both catheters were connected to another catheter that was introduced in the right external jugular vein up to the superior vena cava (2 cm). The catheter of the inflow line to the lliver (coming from the perfusion system) was introduced in the left branch of the portal vein (1 cm). The infrahepatic caval vein (above the right renal vein) and the suprahepatic caval vein were clamped. The hepatic artery and the bile duct distal to the paramedian ducts coming from the right lateral and caudate lobes were ligated during perfusion (not shown). A silastic catheter inserted into the infrahepatic caval vein established an outflow line of the liver (coming back to the perfusion system). The bile duct catheter was identified, its free tip was open and bile was harvested during perfusion (not shown
).
Surgical procedures
Surgical procedures were performed under light ether anesthesia in clean but nonsterile conditions. All rats Gene Therapy received 80 mg of penicillin and 133 mg of streptomycin per kg i.m. before each procedure. 41 Partial hepatectomy First, the bile duct draining the left lateral and median lobes was cannulated with a 10 cm long silastic catheter (inner diameter 0.30 mm and outer diameter 0.64 mm, Dow Corning, Sophia Antipolis, France): 2 to 3 mm of the catheter was introduced into the bile duct, above the paramedian ducts draining the right lateral and caudate lobes (Figure 3b) . The catheter was secured with two ligatures placed around the bile duct and the branches of the hepatic artery assigned to the left lateral and median lobes. The bile duct and hepatic artery were divided above the ligatures. The free tip of the catheter was ligated. A devascularization of the median and left lateral lobes was performed as follows. The branch of the portal vein to the right part of the median lobe was dissected in the hilum and into the liver parenchyma (1 cm), and cut between ligatures. The remaining portal vein was dissected in the hilum up to the branch assigned to the left part of the median lobe and the branch to the left lateral lobe, which were cut between ligatures. We therefore obtained right and left branches of the portal vein of about 1 cm long each, above the branches of the portal vein assigned to the right lateral and caudate lobes (Figure 3c) . The right and left suprahepatic veins were isolated into the parenchyma of the median lobe and ligated as close as possible to the inferior vena cava. Partial hepatectomy was then performed and the left lateral and median lobes were removed. 21 The abdomen was then closed.
In vivo, in situ normothermal isolated regenerating rat liver perfusion technique Twenty-four hours after partial hepatectomy, the remaining two lobes were completely excluded from the splanchnic circulation. The ligaments of the liver were sectioned. The left hepatic artery and right adrenal vein were cut between ligatures. An extracorporeal shunt drained the blood flow from both the portal vein and infrahepatic caval vein into the right external jugular vein. A silastic catheter (inner diameter 0.64 mm and outer diameter 1.19 mm, Dow Corning) was introduced in the right branch of the portal vein until 2-3 mm beyond the gastroduodenal vein (Figure 4) . The portal vein above the gastroduodenal vein was ligated around this catheter. Another catheter (inner diameter 0.64 mm and outer diameter 1.19 mm, Dow Corning) was introduced in the right lumbar vein. Both catheters were connected to another catheter (inner diameter 1.0 mm and outer diameter 1.7 mm, Vygon, Ecouen, France) that was introduced in the right external jugular vein up to the superior vena cava (2 cm). The catheter of the inflow line to the liver (coming from the perfusion system) was introduced in the left branch of the portal vein (1 cm). The infrahepatic caval vein above the right renal vein, the hepatic artery and the suprahepatic caval vein were clamped. A silastic catheter (inner diameter 1.47 mm and outer diameter 1.96 mm, Dow Corning) was inserted into the infrahepatic caval vein (above the right renal vein) to establish the outflow line from the liver (coming back to the perfusion system). The bile duct distal to the paramedian ducts coming from the right lateral and caudate lobes was ligated. The bile duct catheter was identified, its free tip was open and bile was harvested during perfusion. The isolated rat liver was perfused in vivo-in situ, completely excluded from systemic circulation, while the extracorporeal shunt drained the blood flow from the portal and infrahepatic caval veins. Care was taken to keep intraperitoneal organs moist with saline during the experiment. Sodium heparin (100-150 IU) was added in the extracorporeal shunt during the experiment.
The perfusion system previously described 42 was modified and the temperature was thermostatically maintained between 36.5-37.5°C. Culture supernatant and culture medium without retroviruses were used as perfusate, in two independent perfusion systems. In a preliminary study (data not shown), there was no deleterious effect of the perfusion system on the retrovirus titration after 1 h of perfusion. The perfusate was oxygenated with a mixture of 95-100% O 2 and 0-5% CO 2 through a membrane exchange oxygenator. 43, 44 Perfusate acid-base (inflow line = left branch of the portal vein and outflow line = infrahepatic vena cava) was adjusted to physiologic parameters (ABL 5, Radiometer, Copenhagen, Denmark). Portal flow was pre-determined at 4 ml/min/g of liver weight. Liver weight (right lateral and caudate lobe) was previously estimated to be 1% of rat body weight. Liver viability was assessed by gross liver appearance, bile flow and oxygen consumption. 45 Oxygen consumption was determined from the difference in oxygen content of the perfusate entering (left branch of the portal vein) and leaving (infrahepatic vena cava) the liver, collected anaerobically. The oxygen consumption was calculated by the following formula:
46 O 2 consumption = {(O 2 in − O 2 out)/2.54688} × HQ, in which O 2 in and O 2 out are the concentrations (vol %) in the portal vein and hepatic veins, respectively, and HQ is the portal vein flow. The isolated rat liver was perfused in vivo-in situ with culture supernatant for 60 min (recirculating system) and then perfused with the culture medium without retroviruses for 30 min (single passage system). The titer of retroviruses in the recirculating perfusate entering (inflow line) and leaving (outflow line) the liver was determined at 30 and 60 min of isolated perfusion. The titer of retroviruses leaving (outflow line) the liver was determined every 5 min while perfusing the liver in a single passage with culture medium without retrovirus. After 90 min of isolated perfusion, infrahepatic caval vein catheter and the catheter draining the portal vein were removed. Clamps were removed from the suprahepatic caval vein and hepatic artery. The right and left branches of the portal vein were ligated, after removing the catheters. The infrahepatic vena cava was sutured. The lumbar and right external jugular veins were ligated after removing the catheters. The ligature of the bile duct was removed. The catheter was removed from the bile duct and its orifice ligated. The abdomen was then closed.
Experimental design
Sixteen rats underwent partial hepatectomy. They were reoperated 24 h later to perform the in vivo-in situ isolated perfusion of the regenerating liver, using as perfusate 25 ml (group I, n = 8) or 50 ml (group II, n = 8) of culture supernatant. At day 4 or 5 after perfusion, they underwent a third operation to take biopsies of liver, spleen, kidney and testis. In order to test for endogenous ␤-galactosidase activity, biopsy samples of the liver, spleen, kidney and testis were also taken in normal rats (n = 3).
Biopsy
Liver biopsy was cut into 5-mm thick blocks, fixed in 4% paraformaldehyde/PBS solution or snap frozen in Tissue-tek OCT compound (Miles, Elkhart, NJ, USA). Samples were also preserved in liquid nitrogen.
Pathology
Sections were stained with hematoxylin, eosin and safran (HES) and by Masson trichrome stain. A standardized report indicated significant alterations of hepatocytes, sinusoids, centrilobular veins and portal tracts, if present.
Histochemical staining for hepatocyte ␤-galactosidase activity Cryostat sections (8 m thick) were fixed (1 h at 4°C) with 0.5% glutaraldehyde and 1% formaldehyde/PBS solution, rinsed three times in PBS at 4°C and stained overnight (12-16 h ) at 37°C, protected from light, for ␤-galactosidase activity with X-gal protocol. Sections were counterstained with hematoxylin, dehydrated and mounted. Arithmetic means of the counts for ␤-galactosidase positive hepatocyte/mm 2 (data not shown), as well as the percentage of ␤-galactosidase-positive hepatocyte, were calculated for each zone in the two groups using the same protocol previously described for quantitative analysis of BrdU hepatocyte nuclei label. 23 Polymerase chain reaction analysis PCRs 47, 48 were performed on 0.5 g high molecular weight DNAs isolated from the liver, spleen, kidney, testis and lymph nodes of rats, 4-5 days after the in vivo-in situ isolated regenerating liver perfusion. Control samples were taken from the same organs from three normal rats. DNA isolations were performed using SDS-proteinase K lysis followed by phenol-chloroform extraction. Synthetic oligodeoxynucleotide primers complementary to the DNA sequences located in the ␤-galactosidase gene OTG 7051 (5′-GCGTTACCCAACTTAATCGCC-3′) and OTG 7052 (5′-ATAACTGCCGTCACTCCAACG-3′) were used. Thirty cycles of amplification by the TaqBead Hot Start Polymerase were performed in a DNA Thermal Cycler (Perkin Elmer Cetus, Norwalk, CT, USA) at temperatures of 94°C (1 min) for denaturation, 60°C (1 min) for hybridization and 72°C (1 min) for elongation. The reaction products were run on 0.8% agarose gel and revealed by ethidium bromide. Specific oligodeoxynucleotide primers sense (5′-ATCACCATTGGCAATGAGCG GTTCC-3′) and antisense (CTCGTCATACTCCTG CTTGCTGAT-3′) for the rat ␤-actin were used as amplification control of the extracted genomic DNA at temperatures of 94°C (30 s) for denaturation, 55°C (1 min) for hybridization and 72°C (1 min) for elongation. 49 
Statistical analysis
All results were expressed as mean ± s.d. Data significance were analysed with a Kruskal-Wallis nonparametric analysis of variance test. For calculating the statistical significance of differences between groups, a Mann and Whitney U test was used. P values Ͻ0.05 were considered to be statistically significant.
